Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul 21;44(28):2595-2605.
doi: 10.1093/eurheartj/ehad328.

High-sensitivity troponins and mortality in the general population

Affiliations

High-sensitivity troponins and mortality in the general population

John W McEvoy et al. Eur Heart J. .

Abstract

Aims: Cardiac troponin T and I can be measured using a number of high-sensitivity (hs) assays. This study aimed to characterize correlations between four such assays and test their comparative associations with mortality.

Methods and results: Among adults without cardiovascular disease in the 1999-2004 National Health and Nutrition Examination Survey, hs-troponin T was measured using one assay (Roche) and hs-troponin I using three assays (Abbott, Siemens, and Ortho). Cox regression was used to estimate associations with all-cause and cardiovascular mortality. Pearson's correlation coefficients comparing concentrations from each assay ranged from 0.53 to 0.77. There were 2188 deaths (488 cardiovascular) among 9810 participants. Each hs-troponin assay [log-transformed, per 1 standard deviation (SD)] was independently associated with all-cause mortality: hazard ratio (HR) 1.20 [95% confidence interval (CI) 1.13-1.28] for Abbott hs-troponin I; HR 1.10 (95% CI 1.02-1.18) for Siemens hs-troponin I; HR 1.23 (95% CI 1.14-1.33) for Ortho hs-troponin I; and HR 1.31 (95% CI 1.21-1.42) for Roche hs-troponin T. Each hs-troponin assay was also independently associated with cardiovascular mortality (HR 1.44 to 1.65 per 1 SD). Associations of hs-troponin T and all-cause and cardiovascular mortality remained significant after adjusting for hs-troponin I. Furthermore, associations of hs-troponin I remained significant after mutually adjusting for hs-troponin I from the other individual assays: e.g. cardiovascular mortality HR 1.46 (95% CI 1.19-1.79) for Abbott after adjustment for the Siemens assay and HR 1.29 (95% CI 1.09-1.53) for Abbott after adjustment for the Ortho assay.

Conclusion: This study demonstrates only modest correlations between hs-troponin T and three hs-troponin I assays and that hs-troponin I assays can provide distinct risk information for mortality in the general population.

Keywords: All-cause mortality; Cardiovascular mortality; High-sensitivity cardiac troponin; NHANES.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest R.H.C. has received grant support from Roche Diagnostics, Fujirebio Diagnostics, Beckman Coulter, Siemens Healthcare Diagnostics, Ortho Clinical Diagnostics, Becton Dickinson, Abbott Diagnostics, Mitsubishi, and Horiba Medical and has consulting agreements with PixCell, Beckman Coulter, Quidel, Siemens Healthineers, and Roche Diagnostics. The other authors report no conflicts of interest relevant to this article.

Figures

Structured Graphical Abstract
Structured Graphical Abstract
CVD, cardiovascular disease; F/U, follow-up; NHANES, National Health and Nutrition Examination Survey; yr, year.
Figure 1
Figure 1
Hazard ratios (95% confidence intervals) for four high-sensitivity troponin assays with all-cause mortality (panel A, high-sensitivity troponin T, Roche; panel B, high-sensitivity troponin I, Siemens; panel C, high-sensitivity troponin I, Abbott; panel D, high-sensitivity troponin I, Ortho) and cardiovascular disease mortality (panel E, high-sensitivity troponin T, Roche; panel F, high-sensitivity troponin I, Siemens; panel G, high-sensitivity troponin I, Abbott; panel H, high-sensitivity troponin I, Ortho) among US adults without a history of cardiovascular disease, NHANES 1999–2004. High-sensitivity troponin was log-transformed and modeled as a restricted cubic spline (solid line). Knots were placed at 5th, 35th, 65th, 95th, percentiles. The shaded areas on each side of the regression line are the 95% confidence intervals. The background shaded area is the distribution (histogram) of each high-sensitivity troponin assay in the population. The models were adjusted for age, sex, race/ethnicity, total cholesterol, high-density lipoprotein cholesterol, systolic blood pressure, cigarette smoking status, diabetes mellitus, family history of cardiovascular disease, body mass index, use of blood pressure medications, use of cholesterol-lowering medications, and estimated glomerular filtration ratio. CI, confidence interval; CVD, cardiovascular disease; Tn, troponin.
Figure 2
Figure 2
Unweighted pairwise correlations between log-transformed high-sensitivity troponin assays among primary prevention US adults aged 18 or older with concentrations above the assay limit of blank, NHANES 1999–2004. Unweighted Scatterplots. Non-linear dashed line, locally weighted scatterplot smoothing; straight unbroken line, linear regression; horizontal and vertical intersecting dashed lines, 99th percentile of troponin in the analytic sample. Participants with high-sensitivity troponin concentrations below the limit of blank for each assay were excluded from correlation analyses. RMSE, root mean square error; NRMSE, normalized root mean square error.

Comment in

References

    1. Raber I, McCarthy CP, Januzzi JL Jr. A test in context: interpretation of high-sensitivity cardiac troponin assays in different clinical settings. J Am Coll Cardiol 2021;77:1357–1367. 10.1016/j.jacc.2021.01.011 - DOI - PubMed
    1. Sandoval Y, Apple FS, Mahler SA, Body R, Collinson PO, Jaffe AS, et al. . High-sensitivity cardiac troponin and the 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR guidelines for the evaluation and diagnosis of acute chest pain. Circulation 2022;146:569–581. 10.1161/CIRCULATIONAHA.122.059678 - DOI - PubMed
    1. Reichlin T, Hochholzer W, Bassetti S, Steuer S, Stelzig C, Hartwiger S, et al. . Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med 2009;361:858–867. 10.1056/NEJMoa0900428 - DOI - PubMed
    1. Twerenbold R, Costabel JP, Nestelberger T, Campos R, Wussler D, Arbucci R, et al. . Outcome of applying the ESC 0/1-hour algorithm in patients with suspected myocardial infarction. J Am Coll Cardiol 2019;74:483–494. 10.1016/j.jacc.2019.05.046 - DOI - PubMed
    1. Omland T, de Lemos JA, Sabatine MS, Christophi CA, Rice MM, Jablonski KA, et al. . A sensitive cardiac troponin T assay in stable coronary artery disease. N Engl J Med 2009;361:2538–2547. 10.1056/NEJMoa0805299 - DOI - PMC - PubMed

Publication types